Meda

Activities: Manufacturing Pharmaceutical

Trending Articles

  1. Amgen pours $900m into US manufacturing capacity with Ohio expansion The biopharmaceutical company will expand the Ohio facility's operations and construct a second manufacturing plant in Holly Springs, North Carolina
  2. Optima strengthens Indian footprint with Pune site expansion The company will hire 40 engineering specialists to expand its presence in both the Indian and wider APAC market
  3. Guardtech Group Commercial Team ready to shine as jam-packed summer exhibition schedule hots up The Suffolk contamination control specialists are set to share their cleanroom construction products and services at shows covering Pharmaceuticals, Biotech, Chemical Process...
  4. Roche to put $50bn into US manufacturing and R&D footprint The company will build new gene therapy, weight loss medication and continuous glucose monitoring manufacturing facilities situated across the US, as well as dedicated R&D centres
  5. PCI Pharma Serives acquires US-based sterile fill-finish CDMO, Ajinomoto Althea This acquisition will add antibody-drug conjugate (ADC) manufacturing and US-based sterile fill-finish production capabilities to PCI's portfolio

Upcoming event

Boosting Sustainability and Efficiency in Pharma Manufacturing

14 May 2025 | Virtual See all

Related Content

Finance

Mylan to acquire Meda in US$9.9bn cash and stock deal

Will create a leading pharma firm with a portfolio of branded and generic medicines and a strong portfolio of over-the-counter products
Manufacturing

DPT Laboratories acquires Meda Pharmaceuticals New Jersey facility

Will meet the current need for additional cold storage and a larger analytical laboratory
Finance

Meda to acquire Rottapharm for around €3bn in cash and shares

Expanding its business in consumer healthcare products and in emerging markets
Finance

Meda to acquire Acton Pharmaceuticals for US$135m

Transaction includes the Aerospan inhaler for the treatment of asthma
Research & Development

Meda expands collaboration with Cipla

Expands its exclusive rights to allergic rhinitis treatment Dymista
Subscribe now